Home > Campaigns > Pre-eclampsia

Pre-eclampsia: Act Early! Screen Early!

Pre-eclampsia is a serious pregnancy complication that can affect both mother and baby. Early detection through prenatal screening is key to managing risks and improving outcomes. Learn how to recognize symptoms, understand risk factors, and take preventive steps to protect your health and your baby’s.

Pre-eclampsia: Symptoms, Risk Factors, and Early Detection

Pre-eclampsia—sometimes called “toxemia of pregnancy”—is a serious pregnancy complication affecting about 2 in 100 expectant mothers. Its primary symptoms include high blood pressure and elevated protein levels in the urine. Pre-eclampsia can pose significant risks to both mother and baby. While severe and early-onset cases (before 34 weeks of gestation) are rare, regular prenatal care is essential to detect the condition early and manage it effectively.

 

If left untreated, pre-eclampsia can progress into more severe conditions such as HELLP syndrome or eclampsia. These complications can be life-threatening for the mother, potentially leading to organ damage or even death. HELLP stands for Hemolysis, Elevated Liver enzymes, and Low Platelet count—the three hallmark symptoms of this dangerous condition.

 

How Does Pre-eclampsia Affect Mother and Baby?

Pre-eclampsia is one of the leading causes of preterm birth. It often restricts the baby’s growth by limiting oxygen and nutrient supply, increasing the risk of low birth weight and developmental complications. Children born to mothers with pre-eclampsia may also face an increased risk of heart and circulatory issues later in life.

 

For mothers, the long-term impact can be equally serious. More than 90% of women who experience severe pre-eclampsia develop chronic high blood pressure within 20 years, and many are at increased risk of cardiovascular disease. Ongoing, expert medical care and a healthy lifestyle—including balanced nutrition, regular physical activity, and stress reduction—are key to managing these risks for both mother and child.

 

What Increases the Risk of Pre-eclampsia?

Several factors can raise the risk of developing pre-eclampsia during pregnancy. These include:

 

  • First-time pregnancy

     

  • Carrying multiples (twins, triplets, etc.)

     

  • A history of pre-eclampsia or fetal growth restriction—either in a previous pregnancy or in a close relative’s pregnancy

     

  • Pregnancy through assisted reproduction, such as artificial insemination or egg donation

     

  • Pre-existing high blood pressure

     

  • Chronic kidney disease

     

  • Diabetes or gestational diabetes

     

  • Overweight or obesity

     

  • Advanced maternal age

 

Understanding your personal risk factors can help ensure closer monitoring and early intervention, reducing the chances of complications for both mother and baby. Regular prenatal check-ups remain the best way to identify and manage potential risks early.

First-Trimester Pre-eclampsia Screening

Although pre-eclampsia typically presents with high blood pressure and increased protein in the urine later in pregnancy, it actually begins developing during the first trimester—often without visible symptoms. Early screening is essential for identifying women at risk and taking preventive steps.

 

Between 11 and 14 weeks of pregnancy, a comprehensive screening can estimate an individual’s risk of developing pre-eclampsia. This assessment includes:

 

  • Blood pressure measurement

     

  • Doppler ultrasound to evaluate blood flow to the uterus

     

  • Maternal blood test to detect specific proteins linked to pre-eclampsia

     

These combined tests can identify a heightened risk well before symptoms appear. If results indicate a high risk, the healthcare provider may recommend lifestyle changes, dietary adjustments, and the use of low-dose aspirin, which has been shown to significantly reduce the risk—especially of early-onset and severe forms of pre-eclampsia.

 

Early detection increases the chances of receiving care from a specialized maternal-fetal medicine center, improving outcomes for both mother and baby.

 

Diagnosing Pre-eclampsia in Later Trimesters

In the second and third trimesters, a blood test analyzing two specific placental proteins can predict the onset of pre-eclampsia up to four weeks in advance. This allows for personalized care, including more frequent prenatal visits, if needed.

What Can Pregnant Women Do?

To protect their health and their baby’s, pregnant women should:

 

  • Attend all scheduled prenatal appointments

     

  • Monitor their blood pressure at home

     

  • Be aware of warning signs, including:
    • Persistent headaches
    • Blurred or impaired vision
    • Sudden weight gain (more than 1 kg or 2.2 lbs per week)
    • Noticeable swelling (especially in hands, feet, or face)
    • Unexplained restlessness or discomfort

 

If any of these symptoms occur, it’s critical to contact a healthcare provider immediately.

 

Monitoring and Managing Diagnosed Pre-eclampsia

Currently, the only cure for pre-eclampsia is delivery. However, in many cases, doctors aim to prolong the pregnancy safely to reduce the risks associated with preterm birth. This requires close monitoring by experienced healthcare professionals, sometimes in a hospital setting.

 

Expert care helps balance the health and safety of both mother and baby, ensuring timely treatment and delivery decisions.

Pre-eclampsia Resources for Patients and Professionals

Want all the key facts about pre-eclampsia at your fingertips? Our pre-eclampsia factsheet covers causes, prevention, and diagnosis after 20 weeks of pregnancy. Download your copy in your preferred language below.

Get quick, essential information on pre-eclampsia—download our flyer and poster to share and spread awareness.

Flyer:

 

Poster:

 

Social Media Toolkit

Transparency

All content in the “Act Early! Screen Early!” campaign was independently developed by GFCNI and reviewed by external experts for medical accuracy. The campaign is powered by GFCNI.

 

We extend our sincere thanks to the following medical societies for their valuable collaboration and support of this campaign.

We thank the following parent and patient organizations for their invaluable support of this campaign around the world.

Thermo Fisher Scientific supported the campaign from 2017 to 2021 but had no influence on its content or messaging.

© 2025 GFCNI. All Rights Reserved.